Back
Insmed Vs. Fulcrum Therapeutics Industry Stock Comparison
Buy
65
INSM
Insmed
Last Price:
73.10
Seasonality Move:
8.45%
Sell
41
FULC
Fulcrum Therapeutics
Last Price:
3.25
Seasonality Move:
57.36%
Buy
65
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $73.15. The Score for INSM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.25. The Score for FULC is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 53.8 | Buy |
| Chaikin Money Flow: | -1314518 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (68.81 - 73.19) | Buy |
| Bollinger Bands (100): | (70.37 - 75.95) | Sell |
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.64 | Sell |
| Chaikin Money Flow: | 580092 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.08 - 3.48) | Sell |
| Bollinger Bands (100): | (3.28 - 8.54) | Sell |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.01 | Buy |
| 20-day SMA: | 70.72 | Buy |
| 50-day SMA: | 72.04 | Buy |
| 200-day SMA: | 54.27 | Buy |
| 8-day EMA: | 71.83 | Buy |
| 20-day EMA: | 71.38 | Buy |
| 50-day EMA: | 71.53 | Buy |
| 200-day EMA: | 58.43 | Buy |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.14 | Buy |
| 20-day SMA: | 3.28 | Sell |
| 50-day SMA: | 3.4 | Sell |
| 200-day SMA: | 7.17 | Sell |
| 8-day EMA: | 3.16 | Buy |
| 20-day EMA: | 3.29 | Sell |
| 50-day EMA: | 4.01 | Sell |
| 200-day EMA: | 5.98 | Sell |
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $1.27 per share.
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and a decrease next year of $0.91 per share.
Insmed Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fulcrum Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||